The Friday before Memorial Day is Don’t Fry Day – a day to raise awareness of sun safety and encourage everyone to take steps to protect their skin.

The US Food and Drug Administration (FDA) has approved the first drug specifically for basal cell carcinoma, the most common type of skin cancer. The drug is called vismodegib (Erivedge)

Learn more about skin cancer in this interactive presentation.

A study published in the Journal of the National Cancer Institute found that people with a history of basal or squamous cell skin cancer (also known as non-melanoma skin cancer) were at an increased risk of developing other cancers later on.